Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspective

Nutrition & Metabolism

Iichiro Shimomura¹  Tohru Funahashi¹  Ken Kishida¹ 

[1] Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, 2-2 B5 Yamada-oka, Suita, Osaka 565-0871, Japan

关键词: metabolic syndrome;    Hokenshido;    health education;    adipocyte dysfunction;    Visceral fat syndrome;   

Others  :  820393
DOI  :  10.1186/1743-7075-8-57

 received in 2011-05-23, accepted in 2011-08-16,  发布年份 2011

【 摘 要 】

The metabolic syndrome has received worldwide recognition and is useful clinical aid in early-preventing atherosclerosis. Visceral adiposity is the main component of the metabolic syndrome in Japan, based on ethnic and racial difference in the pattern of adiposity. In the Amagasaki Visceral Fat Study, subjects had undergone annual health check-ups and then received health education by medical personnel. Visceral fat reduction improved hypoadiponectinemia and the number of obesity-related cardiovascular risk factors, and effectively prevented cardiovascular events. The health education that includes voluntary lifestyle modification aimed at reducing visceral fat could be useful in preventing cardiovascular events in the metabolic syndrome.

【 授权许可】

   
2011 Kishida et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y: Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999, 38:202-206.
• [2]Kishida K, Funahashi T, Matsuzawa Y, Shimomura I: Visceral adiposity as a target for the management of the metabolic syndrome: A Japanese perspective. Ann Med 2011, in press.
• [3]Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Ryo M, Okita K, Iwahashi H, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: Absolute value of bioelectrical impedance analysis-measured visceral fat area with obesity-related cardiovascular risk factors in Japanese workers. J Atheroscler Thromb 2010, 17:1237-1245.
• [4]Okauchi Y, Nishizawa H, Funahashi T, Ogawa T, Noguchi M, Ryo M, Kihara S, Iwahashi H, Yamagata K, Nakamura T, Shimomura I, Matsuzawa Y: Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care 2007, 30:2392-2394.
• [5]Ryo M, Nakamura T, Funahashi T, Noguchi M, Kishida K, Okauchi Y, Nishizawa H, Ogawa T, Kojima S, Ohira T, Okita K, Iwahashi H, Imagawa A, Matsuzawa Y, Shimomura I: Health education program reduced prevalence of the metabolic syndrome in the Amagasaki Visceral Fat Study. Three year follow up study of 3,174 Japanese employees. Intern Med 2011, 50:1643-1648.
• [6]Tamba S, Nishizawa H, Funahashi T, Okauchi Y, Ogawa T, Noguchi M, Fujita K, Ryo M, Kihara S, Iwahashi H, Yamagata K, Nakamura T, Shimomura I, Matsuzawa Y: Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med 2008, 47:1175-1180.
• [7]Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Ryo M, Okita K, Iwahashi H, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population. Diabetes Care 2009, 32:e122.
• [8]Kamada Y, Nakamura T, Funahashi T, Ryo M, Nishizawa H, Okauchi Y, Fukushima J, Yoshida Y, Kiso S, Shimomura I, Hayashi N: Visceral obesity and hypoadiponectinemia are significant determinants of hepatic dysfunction: An epidemiologic study of 3,827 Japanese subjects. J Clin Gastroenterol 2009, 43:995-1000.
• [9]Tamba S, Nakatsuji H, Kishida K, Noguchi M, Ogawa T, Okauchi Y, Nishizawa H, Imagawa A, Nakamura T, Matsuzawa Y, Funahashi T, Shimomura I: Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men. Atherosclerosis 2010, 211:601-605.
• [10]Nakatsuji H, Kishida K, Funahashi T, Noguchi M, Ogawa T, Okauchi Y, Nishizawa H, Nakamura T, Matsuzawa Y, Shimomura I: One-year reductions in body weight and blood pressure, but not in visceral fat accumulation and adiponectin, improve urinary albumin-to-creatinine ratio in middle-aged Japanese men. Diabetes Care 2010, 33:e110-111.
• [11]Okauchi Y, Kishida K, Funahashi T, Noguchi M, Morita S, Ogawa T, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: 4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki Visceral Fat Study. Atherosclerosis 2010, 212:698-700.
• [12]Akita-Fukuda E, Iwahashi H, Okauchi Y, Okita K, Noguchi M, Ogawa T, Ryo M, Kishida K, Funahashi T, Nakamura T, Matsuzawa Y, Imagawa A, Shimomura I: Predictors of deterioration of glucose tolerance and effects of lifestyle intervention aimed at reducing visceral fat in normal glucose tolerance subjects with abdominal obesity. J Diabetes Invest 2011, (2):218-224.
• [13]Carlström M: Seasonal variation may affect clinical diagnosis of metabolic syndrome. Hypertens Res 2010, 33:531-533.
• [14]Partonen T: Metabolic syndrome follows a seasonal cycle. Hypertens Res 2010, 33:534.
• [15]Kamezaki F, Sonoda S, Tomotsune Y, Yunaka H, Otsuji Y: Seasonal variation in metabolic syndrome prevalence. Hypertens Res 2010, 33:568-572.